What other STI testing should we do for a patient with chlamydia? by Patel, Minal et al.
64	 vol 56, No 1 / jaNuary 2007  The Journal of family PracTice
CliniCal INquIrIes From the Family Physicians 
Inquiries Network
What	other	STI	testing		
should	we	do	for	a	patient		
with	chlamydia?	
e v i d e n c e - b a s e d  a n s w e r
Testing for gonorrhea is recommended 
for a patient with genital chlamydia; also 
test for gonorrhea and chlamydia in their 
sexual partner because of the high  
prevalence of coinfection, particularly 
among younger patients (strength of  
recommendation [sor]: c, based on 
expert opinion and observational studies). 
Testing for syphilis and HIv is also  
recommended for the patient and their 
partner (sor: c, based on expert  
opinion).
c l i n i c a l  c o m m e n t a r y
counsel younger adults and teens  
regarding the risks for STis by taking  
an adequate sexual history
Many outpatient labs offer combined 
upfront testing of chlamydia and gonor-
rhea—the information here supports that 
approach. More important, the recom-
mendation to “screen” all patients seeking 
treatment for sexually transmitted infec-
tions (sTIs) for HIv carries an essential un-
derlying message: the need to talk with and 
counsel our patients, especially younger 
adults and teens, regarding their risks for 
sTIs by taking an adequate sexual history. 
   The Centers for Disease Control and 
Prevention (CDC) suggests one organized 
approach using “The Five Ps”: Partners 
(gender, number), Prevention of pregnancy, 
Protection from sTIs, Practices (type of sex 
and condom use), Past history of sTIs. This 
important conversation not only guides  
decisions about completing testing for 
other sTIs but provides an avenue for  
potentially life-saving conversations.  
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æ Evidence	Summary
A pilot study evaluated the yield of test-
ing patients for other STIs among pa-
tients with genital chlamydia diagnosed 
during opportunistic screening. The study 
screened patients of both sexes in prima-
ry health care settings, as well as men at-
tending a genitourinary medicine clinic. 
All patients testing positive in the com-
munity were advised to attend the genito-
urinary medicine clinic for STI screening, 
partner notification, and testing of patients 
and their contacts. More than 90% of the 
patients testing positive for chlamydia at-
tended the genitourinary medicine clinic 
for management (total numbers seen in 
the clinic; women n=1245 [957 screened 
in the community] and men n=490 [280 
screened in the community]). 
At the clinic, further workup included 
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evaluation and testing for chlamydia, gon-
orrhea, trichomonas, and bacterial vagi-
nosis. Of the patients whose initial screen-
ing was in the genitourinary medicine 
clinic, 28% had an additional STI. Of the 
patients initially screened in the commu-
nity setting, 4% had another STI. Partner 
testing showed that 55% of male partners 
of female patients had an STI and 76% of 
female partners of male patients had one 
or more STI.1
The high prevalence of coinfection of 
chlamydia and gonorrhea has been shown 
in several studies. One cross-sectional study 
of new clients to a hospital-based STI clinic 
with gonorrhea, chlamydia, or both infec-
tions found 39% of 1239 women and 24% 
of 1141 heterosexual men with gonorrhea 
also had chlamydia. Thirteen percent of fe-
males and 19% of heterosexual males with 
chlamydia also had gonorrhea. More than 
half of the women and a third of the men 
aged 15 to 19 had both gonorrhea and chla-
mydia. Patients with both STIs tended to be 
younger than those with one.2 A study of the 
prevalence rate of chlamydia, gonorrhea, and 
their coinfection in an adolescent population 
(women n=131,915 and men n=71,074) of 
juvenile detention centers between 1997 and 
2002 found that 18% of women and 13% 
of males with chlamydia were coinfected 
with gonorrhea.3 In non–STI clinic settings, 
gonorrhea has been found in 9% of men4,5 
and 6% of women5 with chlamydia.
Recommendations	from	others
The American Academy of Family Physi-
cians (AAFP) strongly recommends testing 
for chlamydia in all sexually active women 
aged 25 years or younger and those at in-
creased risk. The AAFP recommends screen-
ing all sexually active women for gonorrhea 
if they are at increased risk for infection; 
strongly recommends screening persons 
at increased risk for syphilis infection; and 
strongly recommends screening for HIV for 
persons seeking treatment for STIs.6
The CDC guidelines recommend 
evaluation, testing and treatment of part-
ners of persons with chlamydia. As well as 
testing for other STIs, the guidelines sug-
gest Pap smear screening for women who 
have not been adequately screened, as 
they often are at high risk for later cervi-
cal cancer.7 All patients seeking treatment 
for STDs, including all patients attending 
STD clinics, should be screened routinely 
for HIV during each visit for a new com-
plaint, regardless of whether the patient is 
known or suspected to have specific be-
havior risks for HIV infection.8
The Institute for Clinical Systems 
Improvement recommends screening for 
chlamydia and gonorrhea for all sexually 
active women aged 25 years and younger 
and other asymptomatic women at risk 
for infection. Routine screening for HIV 
is also recommended to all persons at high 
risk, including those seeking treatment for 
any STI.9
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